EFFECT OF MAGNESIUM SUPPLEMENTATION ON REDUCTION OF HBA1C IN NORMOTENSIVE TYPE 2 DIABETIC PATIENTS TAKING ORAL ANTI-DIABETIC DRUGS
DOI:
https://doi.org/10.71000/wy3w1688Keywords:
Blood Glucose; Diabetes Mellitus, Type 2; Hemoglobin A, Glycosylated; Hypoglycemic Agents; Magnesium; Magnesium Oxide; MicronutrientsAbstract
Background: Type 2 diabetes mellitus is commonly accompanied by micronutrient imbalance, and magnesium deficiency has emerged as a potentially important contributor to poor glycemic control. Reduced magnesium levels may impair insulin secretion, worsen insulin resistance, and disrupt glucose metabolism. Although magnesium supplementation has shown potential benefit in improving glycemic indices, locally relevant evidence remains limited, particularly in normotensive patients with type 2 diabetes mellitus receiving oral anti-diabetic drugs without insulin or antihypertensive therapy.
Objective: To determine the effect of magnesium supplementation on reduction of HbA1c in normotensive patients with type 2 diabetes mellitus taking oral anti-diabetic drugs.
Methods: This comparative analytical study was conducted in the Department of Medicine, Combined Military Hospital, Peshawar, over six months. A total of 180 patients aged 30–65 years with known type 2 diabetes mellitus were enrolled through non-probability consecutive sampling after informed written consent. Only normotensive patients receiving oral anti-diabetic drugs were included. Participants were divided into two equal groups based on treatment status: one group received magnesium oxide 400 mg once daily in addition to routine oral anti-diabetic therapy, while the other continued standard oral anti-diabetic treatment alone. Demographic, clinical, and biochemical data were collected using a structured proforma. Variables included age, sex, duration of diabetes, body mass index, serum magnesium, fasting plasma glucose, and HbA1c. Data were analyzed using SPSS version 26. Independent-samples t-test and chi-square test were applied as appropriate, and p<0.05 was considered statistically significant.
Results: A total of 180 participants were analyzed, with 90 patients in each group. Baseline characteristics were comparable between the two groups. Mean age was 52.1 ± 7.8 years in the magnesium group and 51.4 ± 8.2 years in the control group. Baseline HbA1c was 8.61 ± 0.84% in the magnesium group and 8.58 ± 0.81% in the control group. After follow-up, HbA1c decreased to 7.99% in the magnesium group and 8.38% in the control group. Mean HbA1c reduction was significantly greater in the magnesium group (-0.62 ± 0.45%) than in the control group (-0.20 ± 0.40%), with a between-group mean difference of -0.42% (95% CI: -0.54 to -0.30; p=0.001). Hypomagnesemia was present in 34.4% of participants and was associated with significantly higher baseline HbA1c (p<0.001).
Conclusion: Magnesium supplementation was associated with better glycemic control and a greater reduction in HbA1c among normotensive patients with type 2 diabetes mellitus receiving oral anti-diabetic therapy. Assessment and correction of magnesium deficiency may offer a simple and affordable adjunctive strategy in diabetes management.
Keywords: Blood Glucose; Diabetes Mellitus, Type 2; Hemoglobin A, Glycosylated; Hypoglycemic Agents; Magnesium; Magnesium Oxide; Micronutrients
References
Piuri G, Zocchi M, Della Porta M et al (2021) Magnesium in obe- sity, metabolic syndrome, and type 2 diabetes. Nutrients 13(2):320. https://doi.org/10.3390/nu13020320
Oost LJ, Kurstjens S, Ma C, Hoenderop JGJ, Tack CJ, de Baaij JHF (2022) Magnesium increases insulin-dependent glucose uptake in adipocytes. Front Endocrinol (Lausanne) 13:986616. https://doi. org/10.3389/fendo.2022.986616
Heidary Z, Khalili H, Mohammadi M, Beigmohammadi MT, Abdollahi A (2020) Effect of magnesium loading dose on insulin resistance in patients with stress-induced hyperglycemia: a rand- omized clinical trial. J Intensive Care Med 35(7):687–693. https:// doi.org/10.1177/0885066618777431
Paolisso G, Sgambato S, Pizza G, Passariello N, Varricchio M, D’Onofrio F (1989) Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects. Diabetes Care 12(4):265–269. https://doi.org/10.2337/diacare.12.4.265
Asbaghi O, Moradi S, Kashkooli S et al (2022) The effects of oral magnesium supplementation on glycaemic control in patients with type 2 diabetes: a systematic review and dose-response meta-analysis of controlled clinical trials. Br J Nutr 128(12):2363–2372. https://doi.org/ 10.1017/s0007114521005201
Bergman, R.N.; Phillips, L.S.; Cobelli, C. Physiologic evaluation of factors controlling glucose tolerance in man: Measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J. Clin. Investig. 1981, 68, 1456–1467. [Google Scholar] [CrossRef]
De Valk, H.; Verkaaik, R.; Van Rijn, H.; Geerdink, R.; Struyvenberg, A. Oral magnesium supplementation in insulin requiring Type 2 diabetic patients. Diabet. Med. 1998, 15, 503–507. [Google Scholar] [CrossRef]
De Lourdes Lima, M.; Cruz, T.; Pousada, J.C.; Rodrigues, L.E.; Barbosa, K.; Cangu, V. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care 1998, 21, 682–686. [Google Scholar] [CrossRef]
Matthews, D.; Hosker, J.; Rudenski, A.; Naylor, B.; Treacher, D.; Turner, R. Homeostasis model assessment: Insulin resistance and -cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28, 412–419. [Google Scholar] [CrossRef] [PubMed]
Bentil HJ, Abreu AM, Adu-Afarwuah S, Rossi JS, Tovar A, Oaks BM. Association between Dietary Magnesium Intake and Glycemic Markers in Ghanaian Women of Reproductive Age: A Pilot Cross-Sectional Study. Nutrients. 2021;13(11).
Oost LJ, van Heck JIP, Tack CJ, de Baaij JHF. The association between hypomagnesemia and poor glycaemic control in type 1 diabetes is limited to insulin resistant individuals. Sci Rep. 2022;12(1):6433.
Güneş M. Association between magnesium level and triglyceride-glucose index in type 2 diabetes mellitus. Magnes Res. 2025;38(3):95-101.
Gu L, Jia S, Chen J. Blood glucose control, magnesium status, and diabetic retinopathy in patients with type 2 diabetes mellitus: Evidence from NHANES 2005-2018. Sci Prog. 2025;108(4):368504251392701.
Yang L, Fan J, Liu Y, Ren Y, Liu Z, Fu H, et al. Case report: Gitelman syndrome with diabetes: Confirmed by both hydrochlorothiazide test and genetic testing. Medicine (Baltimore). 2023;102(24):e33959.
Naseeb M, Bruneau ML, Milliron BJ, Sukumar D, Foster GD, Smith SA, et al. Changes in Dietary Magnesium Intake and Risk of Type 2 Diabetes Mellitus in Middle School Students: Using Data from the HEALTHY Study. J Nutr. 2021;151(11):3442-9.
Kateel R, Kashyap NN, Reddy SK, Shetty S, Kumari MK, Ullal SD, et al. Chronic β-carotene, magnesium, and zinc supplementation together with metformin attenuates diabetes-related complications in aged rats. Clin Nutr. 2025;50:183-97.
Santos C, Santos BDC, de Carvalho GB, Oliveira JS, Santos CB, Reis AR, et al. Magnesium Status and Dietary Patterns Associated with Glycemic Control in Individuals with Type 2 Diabetes Mellitus. Biol Trace Elem Res. 2023;201(11):5152-61.
Maqrashi NA, Busaidi SA, Al-Rasbi S, Alawi AMA, Al-Maqbali JS. Effect of Magnesium Supplements on Improving Glucose Control, Blood Pressure and Lipid Profile in Patients With Type 2 Diabetes Mellitus: A systematic review and meta-analysis. Sultan Qaboos Univ Med J. 2025;25(1):382-94.
Asbaghi O, Moradi S, Kashkooli S, Zobeiri M, Nezamoleslami S, Hojjati Kermani MA, et al. The effects of oral magnesium supplementation on glycaemic control in patients with type 2 diabetes: a systematic review and dose-response meta-analysis of controlled clinical trials. Br J Nutr. 2022;128(12):2363-72.
Mm S, Js N, M BC, Ap M, Mj F, F M, et al. Higher magnesium levels are associated with better glycaemic control and diabetes remission post-bariatric surgery. BMC Endocr Disord. 2022;22(1):303.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Dr Shah Nawaz Khan, Dr Abid Sharif, Dr Maryam Hussain, Dr Muhammad Yasin, Dr Khayam, Dr Syed Sibtain Maqsood (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
